What is the standard of care for septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Standard of Care for Septic Shock

Septic shock is a medical emergency requiring immediate treatment with aggressive fluid resuscitation (at least 30 mL/kg IV crystalloids within 3 hours), followed by norepinephrine as the first-line vasopressor to maintain MAP ≥65 mmHg, plus broad-spectrum antibiotics within 1 hour of recognition. 1, 2

Immediate Recognition and Resuscitation (First 3 Hours)

The Surviving Sepsis Campaign 2016 guidelines establish that sepsis and septic shock are medical emergencies where treatment must begin immediately. 1, 2 The initial approach follows a structured algorithm:

Fluid Resuscitation

  • Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours (strong recommendation). 1, 2
  • Use crystalloids as the fluid of choice (strong recommendation, moderate quality evidence). 1
  • Either balanced crystalloids or saline are acceptable (weak recommendation). 1
  • Albumin may be added when patients require substantial amounts of crystalloids (weak recommendation). 1
  • Avoid hydroxyethyl starches (strong recommendation, high quality evidence). 1, 3

Fluid Challenge Technique

Continue fluid administration as long as hemodynamic improvement occurs, assessed by:

  • Dynamic variables (pulse pressure variation, stroke volume variation)
  • Static variables (arterial pressure, heart rate, urine output)
  • Clinical examination findings 1

Critical pitfall: Stop fluid resuscitation if hepatomegaly or rales develop, as this indicates fluid overload requiring inotropic support rather than additional fluids. 3

Vasopressor Therapy

First-Line Agent

Norepinephrine is the first-choice vasopressor (strong recommendation, moderate quality evidence) to target MAP of 65 mmHg. 1, 3 This represents the highest level recommendation in the guidelines.

Second-Line Options

When additional agents are needed:

  • Add vasopressin (0.03 units/min) to raise MAP or decrease norepinephrine dosage (weak recommendation, moderate quality evidence). 1
  • Add epinephrine when additional agent needed to maintain blood pressure (weak recommendation, low quality evidence). 1, 3

Agents to Avoid or Use Sparingly

  • Dopamine: Only in highly selected patients with low tachyarrhythmia risk and bradycardia (weak recommendation). 1, 3
  • Low-dose dopamine for renal protection: Strongly recommended against (strong recommendation, high quality evidence). 1
  • Phenylephrine: Not recommended except when norepinephrine causes serious arrhythmias, cardiac output is high with persistently low BP, or as salvage therapy. 1

Antimicrobial Therapy

  • Obtain blood cultures before antibiotics (at least 2 sets, one percutaneous and one through vascular access if present). 1
  • Administer broad-spectrum antibiotics within 1 hour of recognizing septic shock (strong recommendation). 3
  • For sepsis without shock, antibiotics should be given within 3 hours. 4

Source Control

Imaging studies should be performed promptly to confirm infection source, and aggressive source control measures implemented when feasible. 3

Hemodynamic Monitoring

  • Target MAP of 65 mmHg initially (strong recommendation, moderate quality evidence). 1
  • Place arterial catheter as soon as practical in all patients requiring vasopressors. 1
  • Use lactate normalization as a resuscitation target in patients with elevated lactate (weak recommendation). 1

Important evolution from prior guidelines: The 2016 guidelines moved away from the rigid early goal-directed therapy (EGDT) protocol that included central venous pressure and central venous oxygen saturation targets. 1 Current recommendations emphasize frequent clinical reassessment using multiple physiologic variables rather than fixed numerical targets.

Inotropic Support

Dobutamine infusion (up to 20 μg/kg/min) should be administered when:

  • Myocardial dysfunction is present (elevated cardiac filling pressures, low cardiac output), OR
  • Ongoing signs of hypoperfusion persist despite adequate volume and MAP (strong recommendation). 1, 3

Adjunctive Therapies

Corticosteroids

Avoid IV hydrocortisone if adequate fluid resuscitation and vasopressor therapy restore hemodynamic stability (weak recommendation). 3 If hemodynamic stability cannot be achieved, consider hydrocortisone 200 mg/day. 3

Nutritional Support

  • Initiate early enteral feeding rather than complete fast (weak recommendation). 1
  • Avoid IV selenium, glutamine, and omega-3 fatty acids as immune supplements (strong recommendations). 1

Goals of Care

Discuss goals of care and prognosis with patients and families as early as feasible, but no later than 72 hours of ICU admission. 1 Incorporate palliative care principles where appropriate (strong recommendation). 1

Quality Assurance

Hospitals should have performance improvement programs for sepsis, including screening protocols for acutely ill, high-risk patients. 1 Recent data from 2026 indicate that structured quality assurance measures covering screening rates, antibiotic timing, and standardized treatment procedures improve outcomes. 4

Evidence Strength Considerations

The strongest recommendations (Grade 1A-1C) in septic shock management are:

  1. Norepinephrine as first-line vasopressor
  2. Against using low-dose dopamine for renal protection
  3. Against using hydroxyethyl starches
  4. Crystalloids as initial fluid choice
  5. Early antibiotic administration

Most other recommendations carry lower quality evidence (Grade 2B-2C), reflecting the complexity of septic shock and heterogeneity of patient responses. Recent research from 2025-2026 emphasizes increasingly individualized approaches based on dynamic phases of immune dysregulation and multimodal perfusion targets, though these remain areas of active investigation. 5, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.